CLEVER HANDELN

Richten Sie Börsennews.de als Startseite ein

Hier klicken

RESMED Aktie

RESMED INC. REGISTERED SHARES DL -,004

ISIN: US7611521078

 | 

WKN: 895878

 | 

Symbol: RME

 | 

Land: USA


24,84 EUR -1,9929%

Die besten Rohstoffaktien der Welt

Zu Ihrem Onlinebroker

kaufen verkaufen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen

RESMED Aktienkurs

: 08:08 ( 15 Min. verzögert)
24,84 €
Letzter Kurs
 -1,99%
Veränderung
 25,34 €
Vortag
 24,84 €
Eröffnungskurs

Nachrichten zur RESMED Aktie auf Börsennews.de

Alle News aus dem Web zur RESMED Aktie

  • 07:39

    Irish med tech used in new sleep-monitoring device

    Technology developed at NovaUCD by BiancaMed, a division of the California company ResMed, is being used in a new wireless sleep-monitoring device that Omron Healthcare has just launched in the Japanese marketplace. BiancaMed...

  • 24.05.

    ResMed Debuts in Japan

    Following an impressive third quarter of fiscal 2012, ResMed Inc. (RMD - Snapshot Report) is leaving no stone unturned to expand its operations further. The company launched its first...

  • 23.05.

    Omron Launches Sleep Monitor With ResMed Technology

    SAN DIEGO, May 23, 2012 /PRNewswire via COMTEX/ -- ResMed Inc. (NYSE:RMD) today announced the launch of the first product in Japan using technology from its recently acquired company, BiancaMed....

  • 23.05.

    Omron Launches Sleep Monitor With ResMed Technology

    SAN DIEGO, May 23, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced the launch of the first product in Japan using technology from its recently acquired company,...

  • 23.05.

    ResMed-sponsored study enrols 1000th participant

    ResMed has enrolled its 1000th participant for a sleep apnoea study, bringing it close to its ultimate aim of reaching 1250 patients for the SERVE-HF test. Starting in 2008, the research hopes to rev…